Fig. 7From: Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancerEvaluation of the immunotherapy and chemotherapy between the two groups. A Comparison of the expression of immune checkpoint molecules between the two groups. B Correlation analysis between the risk score and immune checkpoint molecules. C Evaluation of the immunotherapy between the two groups. D Evaluation of the chemotherapy between the two groups. E Evaluation of the chemotherapy drugs based on the key genes in the modelBack to article page